Search research articles
Contact Us
Filters
Showing results (21-30 of 317) with videos related to
Page
of 32
Sort By:
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry
|
July 15, 2006
Death ligands and autoimmune demyelination
Orhan Aktas, Timour Prozorovski, Frauke Zipp
Journal of Neuroimmunology
|
January 16, 2007
Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets
Orhan Aktas, Sonia Waiczies, Frauke Zipp
Expert Opinion on Therapeutic Targets
|
October 13, 2018
EGFL7 - a potential therapeutic target for multiple sclerosis?
Timo Uphaus, Frauke Zipp, Catherine Larochelle
Cellular and Molecular Life Sciences : CMLS
|
April 24, 2016
Erratum to: Dendritic cells as therapeutic targets in neuroinflammation
Felix Luessi, Frauke Zipp, Esther Witsch
Cellular and Molecular Life Sciences : CMLS
|
March 14, 2016
Dendritic cells as therapeutic targets in neuroinflammation
Felix Luessi, Frauke Zipp, Esther Witsch
Expert Review of Neurotherapeutics
|
October 22, 2014
Remyelinating strategies in multiple sclerosis
Felix Luessi, Tanja Kuhlmann, Frauke Zipp
JAMA Neurology
|
October 23, 2013
Identification of inflammatory neuronal injury and prevention of neuronal damage in multiple sclerosis: hope for novel therapies?
Frauke Zipp, Ralf Gold, Heinz Wiendl
Science Signaling
|
March 28, 2008
Geranylgeranylation but not GTP-loading of Rho GTPases determines T cell function
Sonia Waiczies, Ivo Bendix, Frauke Zipp
Results and Problems in Cell Differentiation
|
October 31, 2006
Cell-cell communication by endocannabinoids during immune surveillance of the central nervous system
Oliver Ullrich, Regine Schneider-Stock, Frauke Zipp
Journal of the Neurological Sciences
|
August 19, 2008
Therapeutic targeting of chemokine signaling in Multiple Sclerosis
Isabell Hamann, Frauke Zipp, Carmen Infante-Duarte
Page
of 32
Search research articles
Search
Showing results (21-30 of 317) with videos related to
Sort By:
Page
of 32
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry
|
July 15, 2006
Death ligands and autoimmune demyelination
Orhan Aktas, Timour Prozorovski, Frauke Zipp
Journal of Neuroimmunology
|
January 16, 2007
Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets
Orhan Aktas, Sonia Waiczies, Frauke Zipp
Expert Opinion on Therapeutic Targets
|
October 13, 2018
EGFL7 - a potential therapeutic target for multiple sclerosis?
Timo Uphaus, Frauke Zipp, Catherine Larochelle
Cellular and Molecular Life Sciences : CMLS
|
April 24, 2016
Erratum to: Dendritic cells as therapeutic targets in neuroinflammation
Felix Luessi, Frauke Zipp, Esther Witsch
Cellular and Molecular Life Sciences : CMLS
|
March 14, 2016
Dendritic cells as therapeutic targets in neuroinflammation
Felix Luessi, Frauke Zipp, Esther Witsch
Expert Review of Neurotherapeutics
|
October 22, 2014
Remyelinating strategies in multiple sclerosis
Felix Luessi, Tanja Kuhlmann, Frauke Zipp
JAMA Neurology
|
October 23, 2013
Identification of inflammatory neuronal injury and prevention of neuronal damage in multiple sclerosis: hope for novel therapies?
Frauke Zipp, Ralf Gold, Heinz Wiendl
Science Signaling
|
March 28, 2008
Geranylgeranylation but not GTP-loading of Rho GTPases determines T cell function
Sonia Waiczies, Ivo Bendix, Frauke Zipp
Results and Problems in Cell Differentiation
|
October 31, 2006
Cell-cell communication by endocannabinoids during immune surveillance of the central nervous system
Oliver Ullrich, Regine Schneider-Stock, Frauke Zipp
Journal of the Neurological Sciences
|
August 19, 2008
Therapeutic targeting of chemokine signaling in Multiple Sclerosis
Isabell Hamann, Frauke Zipp, Carmen Infante-Duarte
Page
of 32